Context Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CNTX and other ETFs, options, and stocks.

About CNTX

Context Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which is dedicated to improving the lives of women living with cancer. It engages in developing advanced small molecule and immunotherapy treatments to transform care for hormone-driven breast and gynecological cancers. 

CEO
Martin A. Lehr
CEOMartin A. Lehr
Employees
5
Employees5
Headquarters
Philadelphia, Pennsylvania
HeadquartersPhiladelphia, Pennsylvania
Founded
2015
Founded2015
Employees
5
Employees5

CNTX Key Statistics

Market cap
29.06M
Market cap29.06M
Price-Earnings ratio
-1.17
Price-Earnings ratio-1.17
Dividend yield
—
Dividend yield—
Average volume
2.68M
Average volume2.68M
High today
$1.88
High today$1.88
Low today
$1.60
Low today$1.60
Open price
$1.70
Open price$1.70
Volume
790.71K
Volume790.71K
52 Week high
$1.88
52 Week high$1.88
52 Week low
$0.47
52 Week low$0.47
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.